CD274 and neoplasm: Inversely, tumor and lymph node T: M ratios at PD-L1 mAb doses of 20 μg and 40 μg increased significantly 2- to 5-fold compared to the [89Zr]Zr-DFO-PD-L1 mAb-only group (Table 3).